Northern Ireland Reaches Deal With Vertex for Access to Kaftrio
Aug 03, 2020 07:00 am | Forest Ray
The government of Northern Ireland reached a deal with Vertex Pharmaceuticals to make Kaftrio (ivacaftor/tezacaftor/elexacaftor) available for cystic fibrosis (CF) patients, once the medication receives its European license. The agreement follows similar ones that the company made recently with England and Wales. “We’re delighted to see Northern Ireland and Vertex Pharmaceuticals reach a deal on […]
The post Northern Ireland Reaches Deal With Vertex for Access to Kaftrio appeared first on Cystic Fibrosis News Today. |
|
|
No hay comentarios:
Publicar un comentario